ARCHIVES

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983